Skip to content

Association between reactive oxygen metabolites and severity of heart failure and future cardiovascular events in heart failure with reduced ejection fraction

Association between reactive oxygen metabolites and severity of heart failure and future cardiovascular events in heart failure with reduced ejection fraction - Heart failure with reduced ejection fraction and reactive oxygen merabolites

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016368
Enrollment
200
Registered
2015-01-28
Start date
2008-02-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure with reduced ejection fraction

Interventions

None listed

Sponsors

Kumamoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with heart failure who were hospitalized in Kumamoto University Hospital

Exclusion criteria

Exclusion criteria: Do not meet diagnostic criteria for heart failure with preserved ejection fraction Acute coronary syndrome Active infection diseases History of malignancy End stage of chronic kidney diseases

Design outcomes

Primary

MeasureTime frame
Composite endopoint of cardiovascular death, non-fatal myocardial infarction, unstable angina pectoris, non-fatal ischemic stroke, re-hospitalization for heart failure, or coronary revascularization

Countries

Japan

Contacts

Public ContactTakanori Tokitsu

Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine

tokitsutakanori@gmail.com81-96-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026